Assignee
TAGWORKS PHARMACEUTICALS B V
NL·7 granted patents·11 pending applications·21 citations·filing 2013–2025
Top patents by PatentIndex Score
18 records- 0192US10376594B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2015·Granted Aug 13, 2019·11 cites·25 claims
- 0289US10004810B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2016·Granted Jun 26, 2018·6 cites·4 claims
- 0385US10967069B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2019·Granted Apr 6, 2021·1 cites·34 claims
- 0485US2024091371A1Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2023·Application pending·0 cites
- 0581US10927139B2Chemically cleavable groupTAGWORKS PHARMACEUTICALS B V·Filed 2013·Granted Feb 23, 2021·2 cites·37 claims
- 0678US2026077076A1Agents for cleaving labels from biomolecules in vivoTAGWORKS PHARMACEUTICALS B V·Filed 2025·Application pending·0 cites
- 0776US11857636B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2021·Granted Jan 2, 2024·0 cites·17 claims
- 0873US11617799B2Cleavable tetrazine used in bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2017·Granted Apr 4, 2023·1 cites·41 claims
- 0967US12186405B2Cleavable tetrazine used in bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2022·Granted Jan 7, 2025·0 cites·33 claims
- 1063US2025114489A1Masked il12 proteinTAGWORKS PHARMACEUTICALS B V·Filed 2023·Application pending·0 cites
- 1160US2021002320A1Chemically cleavable groupTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 1259US2022331458A1Agents for cleaving labels from biomolecules in vivoTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 1354US2024207434A1Methods for preparing cyclooctenes andconjugates thereofTAGWORKS PHARMACEUTICALS B V·Filed 2022·Application pending·0 cites
- 1451US2021308207A1Compounds comprising a linker for increasing transcyclooctene stabilityTAGWORKS PHARMACEUTICALS B V·Filed 2019·Application pending·0 cites
- 1549US2022356169A1Tetrazines for high click release speed and yieldTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 1647US2023121556A1Compounds for fast and efficient click releaseTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 1746US2015297741A1Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2013·Application pending·0 cites
- 1846US2021299286A1Tetrazines for high click conjugation yield in vivo and high click release yieldTAGWORKS PHARMACEUTICALS B V·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TAGWORKS PHARMACEUTICALS B V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →